
Is AbbVie Stock a Buy?
The pharmaceutical giant has been a roller coaster over the past several months. It's been a stomach-churning past few months for investors in pharmaceutical giant AbbVie (ABBV 0.62%). A potential blockbuster drug that AbbVie spent roughly $9 billion …